1.
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: What to prescribe in daily clinical practice?
2.
3.
4.
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
5.
6.
7.
8.
9.